FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084700 [Registered on: 13/04/2025] Trial Registered Prospectively
Last Modified On: 09/04/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   Role of neck ultrasound in assessing whether the patient require fluids after surgery 
Scientific Title of Study   CAROTID ULTRASOUND MEASUREMENTS FOR ASSESSING FLUID RESPONSIVENESS IN SPONTANEOUSLY BREATHING POST OPERATIVE ABDOMINAL ONCO-SURGERY PATIENTS 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  HARSIMRAN SINGH WALIA 
Designation  associate professor 
Affiliation  Homi Bhabha Cancer Hospital and research centre, New Chandigarh 
Address  homi bhabha cancer hospital- New Chandigarh- punjab

Sangrur
PUNJAB
140901
India 
Phone  09960375222  
Fax    
Email  harsimranwalia@ymail.com  
 
Details of Contact Person
Scientific Query
 
Name  HARSIMRAN SINGH WALIA 
Designation  associate professor 
Affiliation  Homi Bhabha Cancer Hospital and research centre, New Chandigarh 
Address  Homi Bhabha cancer hospital- New Chandigarh

Sangrur
PUNJAB
140901
India 
Phone  09960375222  
Fax    
Email  harsimranwalia@ymail.com  
 
Details of Contact Person
Public Query
 
Name  HARSIMRAN SINGH WALIA 
Designation  associate professor 
Affiliation  Homi Bhabha Cancer Hospital and research centre, New Chandigarh 
Address  homi bhabha cancer hospital- New Chandigarh- punjab

Sangrur
PUNJAB
140901
India 
Phone  09960375222  
Fax    
Email  harsimranwalia@ymail.com  
 
Source of Monetary or Material Support  
Homi Bhabha Cancer Hospital- New Chandigarh- Anesthesia department- 5th floor OT complex Punjab-140901 
 
Primary Sponsor  
Name  nil 
Address  NA 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NA  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
harsimran singh walia  homi bhaba cancer hospital and research centre, new chandigarh  OT COMPLEX- 5TH FLOOR- DEPARTMENT OF ANAESTHESIA, CRITICAL CARE AND PAIN
Sangrur
PUNJAB 
09960375222

harsimranwalia@ymail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC HBCHRC, NEW Chandigarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C269||Malignant neoplasm of ill-definedsites within the digestive system, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  DVPeak after fluid as a measure of fluid responsiveness  DV Peak will be measured as a measure of fluid responsiveness after giving fluid bolus 
Intervention  FTc after giving IV fluid bolus  Postoperative patients meeting the inclusion criteria will be included in the study after approval from IEC. First, baseline carotid FTc, DVpeak, stroke volume index (SVI), and haemodynamic data will be measured. After recording these data, the patients will be administered a fluid challenge of 6 ml/ kg ideal body weight of ringer lactate over 10 min. Five minutes after completion of the fluid challenge, the same haemodynamic parameters will be measured again. No vasoactive medications will be administered during the measurement period, and all measurements will be obtained while the patients were haemodynamically stable. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Age 18 years to 80 years
2. left ventricular outflow track time integral greater than 15%
3.SBP less than 90mm hg
4. Hear rate more than 100/min
5. Urine output less than 0.5ml/kg/hour
 
 
ExclusionCriteria 
Details  1. Pregnancy
2. Chronic kidney disease on Hemodialysis
3. BMI more than 35 or less than 15
4. Presence of carotid artery stenosis
5.cardiac arrthymias
6. patients of vasopressors 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The aim of this study will be to compare carotid FTc as determined by Doppler ultrasound versus DVpeak for fluid responsiveness in spontaneously br
eathing patients as a predictor of fluid responsiveness in spontaneously breathing patients after abdominal oncosurgery.
 
The aim of this study will be to compare carotid FTc as determined by Doppler ultrasound versus DVpeak for fluid responsiveness in spontaneously br
eathing patients as a predictor of fluid responsiveness in spontaneously breathing patients after abdominal oncosurgery.
TO BE ASSESSED FROM POST OPERATIVE DAY-0 TILL ICU DISCHARGE
 
 
Secondary Outcome  
Outcome  TimePoints 
Change in Heart rate, mean arterial pressure, Systolic blood pressure, Diastolic blood pressure and respiratory rate will be noted  Postoperative period 
 
Target Sample Size   Total Sample Size="42"
Sample Size from India="42" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   We will compare FTc and DV peak as a marker of fluid responsiveness in patients who are administered fluids in postoperative period. 
Close